Skip to main content

Table 3 Adjuvant treatment after surgery

From: Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

 

A (BVZ + CAPE + RT) (N = 44)

B (CAPE + RT) (N = 46)

Total (N = 90)

Patients receiving adjuvant chemotherapy

 No

n (%)

10 (22.73)

5 (10.87)

15 (16.67)

 Yes

n (%)

34 (77.27)

41 (89.13)

75 (83.33)

 Adjuvant schedule

 capecitabine

n (%)

18 (40.9)

21 (45.65)

39 (43.33)

 XELOX

n (%)

10 (22.73)

15 (32.61)

25 (27.78

 FOLFOX

n (%)

6 (13.64)

8 (17.39)

14 (15.56)

 Oxaliplatin + Raltitrexed

n (%)

1 (2.27)

1 (2.17

2 (2.22)

 5-Fu

n (%)

2 (4.34)

2 (2.22)